Table: SymBio Pharmaceuticals - 9-MTH parent results

SymBio Pharmaceuticals

11/11/2021 06:30

Nov 11 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               5.55                2.33             9.15     
                  (+138.1 pct)         (+16.2 pct)     (+206.4 pct) 
  Operating          424 mln            loss 3.14          1.36     
  Recurring          414 mln            loss 3.22          1.35     
  Net                324 mln            loss 2.69          1.15     
  EPS               8.48 yen         loss 84.59 yen      29.99 yen  
  EPS Diluted       8.36 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T